Determination of voriconazole in human plasma by HPLC-ESI-MS and application to pharmacokinetic study

J Chromatogr Sci. 2013 Jul;51(6):485-9. doi: 10.1093/chromsci/bms178. Epub 2012 Nov 11.

Abstract

A fast, sensitive, high-performance liquid chromatography-tandem mass spectrometry method was developed for the determination of voriconazole in human plasma. Carbamazepine was used as the internal standard and the sample pretreatment involved one-step protein precipitation. Chromatographic separation was conducted on an Ultimate C18 column with a mobile phase consisting of acetonitrile-water (containing 0.1% formic acid; 40:60, v/v) at a flow rate of 0.3 mL/min. The detection of voriconazole was performed on a triple-quadrupole tandem mass spectrometer by multiple reaction monitoring with an electrospray ionization source in the positive mode. The standard curve was linear (r(2) ≥ 0.99) within the concentration range of 2.49-293 ng/mL. The intra-day and inter-day precision values were below 5.3%, and the accuracy was within -4.3-5.7%. The method was applicable to the clinical study of the pharmacokinetics of voriconazole in healthy volunteers following oral administration.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Humans
  • Least-Squares Analysis
  • Male
  • Pyrimidines / blood*
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrometry, Mass, Electrospray Ionization / methods*
  • Triazoles / blood*
  • Triazoles / chemistry
  • Triazoles / pharmacokinetics
  • Voriconazole

Substances

  • Pyrimidines
  • Triazoles
  • Voriconazole